BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241121
DTSTAMP:20260515T144716
CREATED:20240808T110613Z
LAST-MODIFIED:20240808T110613Z
UID:39537-1731888000-1732147199@www.pharmajournalist.com
SUMMARY:2nd Donor Selection & Cell Source Summit
DESCRIPTION:Join us at the 2nd Donor Selection & Cell Source Summit – an unparalleled event dedicated to revolutionizing donor testing\, screening\, and cell source selection. This is your chance to be at the forefront of scalable allogeneic manufacturing and streamline both supply chain and process development. \nWhy Attend? \n\nDive Deep: Explore the latest global regulatory requirements and donor testing innovations.\nCutting-Edge Insights: Learn about breakthrough genome sequencing data transforming donor selection.\nForge Connections: Network with leading companies like Bristol Myers Squibb\, ImmuneBridge\, and Deverra Therapeutics.\nExclusive Access: Discover strategies to partner with donation sites and secure access to elite donor pools.\n\nBy refining our donor selection processes today\, we can revolutionize the future of allogeneic therapies and significantly enhance patient outcomes. \nLearn more here.
URL:http://www.pharmajournalist.com/event/2nd-donor-selection-cell-source-summit/
LOCATION:DoubleTree by Hilton Hotel San Diego – Mission Valley\, 7450 Hazard Center Dr\, San Diego\, CA\, 92108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241122
DTSTAMP:20260515T144716
CREATED:20240805T115824Z
LAST-MODIFIED:20240805T115824Z
UID:39492-1731974400-1732233599@www.pharmajournalist.com
SUMMARY:8th Antifibrotic Drug Development Summit
DESCRIPTION:The landmark FDA approval of the first MASH therapeutic\, the orphan drug designation for systemic sclerosis trials\, and the rapid advancement of IPF treatments through clinical phases have ignited a transformative era in fibrosis research. Now more than ever experts are doubling down on fibrosis. \nAs the focus on innovative therapies intensifies\, there is a pressing need for cutting-edge strategies that can overcome preclinical and clinical challenges has never been more critical. With that\, I’m delighted to announce the return of the 𝗔𝗻𝘁𝗶𝗳𝗶𝗯𝗿𝗼𝘁𝗶𝗰 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝘂𝗺𝗺𝗶𝘁 for its 𝟴𝘁𝗵 𝘆𝗲𝗮𝗿 as the fibrosis community’s premier event\, uniting industry experts and key opinion leaders across Pulmonology\, Hepatology\, Rheumatology\, Nephrology\, Cardiology\, and Gastroenterology. \nGathering decision makers to share cross fibrosis insights on innovative strategies to navigate the shared fibrosis challenges from discovery to novel targets\, preclinical models\, biomarkers\, and early-stage clinical trials. Gain exclusive insights and strategies to apply to your own research accelerating the development of truly transformative\, disease-modifying\, ‘antifibrotic’ therapeutics. \nWhether focusing on 𝗜𝗣𝗙\, 𝗠𝗔𝗦𝗛\, 𝘀𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝘀𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀\, 𝗸𝗶𝗱𝗻𝗲𝘆 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀\, 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀\, 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝗻𝗴 𝗜𝗕𝗗 or 𝗮𝗻𝗼𝘁𝗵𝗲𝗿\, this summit is your collective forum to propel innovative and efficacious antifibrotic therapeutics to patients in need. \nJoin us at the 8th AFDD Summit to be part of the conversation\, share your insights\, and discover the innovations that are transforming fibrosis treatment. \nTo know more visit: https://ter.li/01itbv
URL:http://www.pharmajournalist.com/event/8th-antifibrotic-drug-development-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241121
DTSTAMP:20260515T144716
CREATED:20240806T120430Z
LAST-MODIFIED:20240809T122433Z
UID:39503-1731974400-1732147199@www.pharmajournalist.com
SUMMARY:LEAP HR: Emerging Biopharma
DESCRIPTION:Mark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to Boston from November 19-20\, this event is designed specifically for CHROs\, CPOs\, and Heads of HR at the heart of Emerging Biopharma organizations. Over the course of two days\, we will unite the most senior leaders from Emerging Biopharma companies across the US for unmissable content and invaluable networking opportunities. \nIn today’s rapidly evolving biotech landscape\, there has never been a more crucial time for HR leaders to come together. With limited resources and funding\, the challenges are greater than ever. LEAP HR: Emerging Biopharma provides a platform to address these challenges head-on\, offering strategies to enhance HR efficiency and prepare for a future brimming with investment and growth opportunities. \nThis event is your best opportunity to delve deeply into the pressing issues that senior leaders face daily. Topics will include rethinking organizational efficiencies\, adapting to new agile working methodologies\, and genuinely engaging and retaining critical biopharma talent. Through a series of insightful sessions\, participants will explore how to build high-impact strategies that align closely with business needs and help navigate today’s volatile biotech market. \nUnveiling of 30+ case studies showcasing how HR leaders are overcoming industry challenges\, gain actionable insights into engaging and developing employees\, retaining essential talent\, and preparing for future adversities. By sharing these real-world examples\, you will leave equipped with the tools you need to foster resilience and innovation within their organizations. \nJoin us in Boston this November for LEAP HR: Emerging Biopharma and become part of a dynamic community of HR leaders dedicated to shaping the future of the biopharma industry. Don’t miss this chance to network with peers\, gain fresh perspectives\, and develop strategies that will help your organization thrive in an increasingly competitive market. Be prepared to return to your organization with renewed energy and practical solutions to drive success in the challenging yet promising world of Emerging Biopharma. \nFind out more now: https://ter.li/jqplmd
URL:http://www.pharmajournalist.com/event/leap-hr-emerging-biopharma/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="LEAP HR":MAILTO:leaphr@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241120
DTEND;VALUE=DATE:20241122
DTSTAMP:20260515T144716
CREATED:20240920T113804Z
LAST-MODIFIED:20240924T114350Z
UID:39796-1732060800-1732233599@www.pharmajournalist.com
SUMMARY:Portfolio Strategy & Decision Making for Biopharma Summit
DESCRIPTION:Join us at the inaugural Portfolio Strategy & Decision Making for Biopharma Summit – the must-attend event for pharma and biotech leaders seeking to sharpen their portfolio strategies in today’s dynamic market. \nGain exclusive insights into leveraging advanced data analytics\, forecasting tools\, and innovative approaches to enhance decision-making. This summit will showcase real-world case studies and best practices from both established big pharma and agile biotech companies\, helping you navigate market volatility with confidence. \nNetwork with over 60 industry leaders and engage in discussions focused on boosting cross-functional collaboration and exploring partnership opportunities. Learn how to align stakeholders\, mitigate risks\, and drive sustainable growth through strategic portfolio management. \nIn an era of rapid change and unprecedented challenges in the biopharma market\, this event is essential for staying ahead. Don’t miss the opportunity to equip yourself with the tools and knowledge to adapt\, respond\, and implement strategies that ensure portfolio success. \nKey Themes Include: \n\nAdvanced data analytics for better decision-making\nRisk mitigation and portfolio optimization\nCross-functional collaboration and partnerships\n\nJoin us to analyze\, adapt\, and respond to today’s biopharma challenges—position yourself for success!
URL:http://www.pharmajournalist.com/event/portfolio-strategy-decision-making-for-biopharma-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR